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A B S T R A C T
Background: Quantification of pharmacokinetic parameters in dynamic contrast enhanced (DCE) MRI is heavily
dependent on the arterial input function (AIF). In the present patient study on advanced stage head and neck
squamous cell carcinoma (HNSCC) we have acquired DCE-MR images before and during chemo radiotherapy.
We determined the repeatability of image-derived AIFs and of the obtained kinetic parameters in muscle and
compared the repeatability of muscle kinetic parameters obtained with image-derived AIF's versus a population-
based AIF.
Materials and methods: We compared image-derived AIFs obtained from the internal carotid, external carotid and
vertebral arteries. Pharmacokinetic parameters (ve, Ktrans, kep) in muscle—located outside the radiation
area—were obtained using the Tofts model with the image-derived AIFs and a population averaged AIF.
Parameter values and repeatability were compared. Repeatability was calculated with the pre- and post-treat-
ment data with the assumption of no DCE-MRI measurable biological changes between the scans.
Results: Several parameters describing magnitude and shape of the image-derived AIFs from the different ar-
teries in the head and neck were significantly different. Use of image-derived AIFs led to higher pharmacokinetic
parameters compared to use of a population averaged AIF. Median muscle pharmacokinetic parameters values
obtained with AIFs in external carotids, internal carotids, vertebral arteries and with a population averaged AIF
were respectively: ve (0.65, 0.74, 0.58, 0.32), Ktrans (0.30, 0.21, 0.13, 0.06), kep (0.41, 0.32, 0.24, 0.18).
Repeatability of pharmacokinetic parameters was highest when a population averaged AIF was used; however,
this repeatability was not significantly different from image-derived AIFs.
Conclusion: Image-derived AIFs in the neck region showed significant variations in the AIFs obtained from
different arteries, and did not improve repeatability of the resulting pharmacokinetic parameters compared with
the use of a population averaged AIF. Therefore, use of a population averaged AIF seems to be preferable for
pharmacokinetic analysis using DCE-MRI in the head and neck area.
1. Introduction
Dynamic contrast enhanced magnetic resonance imaging (DCE-
MRI) can be used to estimate tissue perfusion and micro vessel per-
meability. The rate constants estimated using Tofts pharmacokinetic
analysis of DCE-MR images (i.e. Ktrans and kep) [1] and their ratio (ve)
reflect physiological parameters such as perfusion, permeability and
cellular density, and can therefore be used to quantitatively assess these
tissue properties. As reviewed by Bernstein et al., quantitative DCE-MRI
biomarkers are potential predictors of prognosis and treatment re-
sponse in head and neck squamous cell carcinoma (HNSCC) [2]. The
validation of these biomarkers is, however, still ongoing, both in the
head-and-neck region as well as in other body parts [3].
One essential requirement for the Tofts pharmacokinetic analysis is
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the knowledge of the arterial input function (AIF). Since the obtained
rate constants are heavily dependent on the AIF [4–8], an accurate and
precise measurement is necessary for their absolute and reliable
quantification. Alternatively, a simplified approach, such as a popula-
tion averaged AIF can be used. However, (large) variabilities in cardiac
output—between patients and within patients over time—are no longer
taken into account with this approach. If this variability in cardiac
output can be accounted for by precise measurement of the AIF, the
accuracy and repeatability of the kinetic parameters should be superior
over use of a population averaged AIF. Some authors have shown that a
population averaged AIF can result in better repeatability [9,10],
whereas others report the opposite [11,12]. It is possible that repeat-
ability depends on the imaged body part and imaging sequence para-
meters, but also on the choice of the artery for AIF measurement.
As recently indicated by the quantitative imaging biomarkers alli-
ance (QIBA) [3], the literature lacks studies on repeatability of quan-
titative (pharmacokinetic model derived) DCE-MRI parameters. This is
especially true in the head and neck region. The repeatability of the AIF
used as input for the model is also only sporadically reported [13,14].
We therefore sought to investigate both the dependence of the AIF re-
peatability on the choice of the artery, as well as the dependence of
repeatability of the pharmacokinetic parameters on the chosen AIF.
In the present patient study on advanced stage head and neck
squamous cell carcinoma (HNSCC) we have acquired DCE-MR images
before and during chemo radiotherapy. Because the second MRI ex-
amination occurs during treatment, while the first occurs before, we are
not able to report on the repeatability of kinetic parameters in HNSCC
tumor tissue. Instead, we chose a neck muscle (left semispinalis capitis
muscle) outside the radiation zone assuming that this muscle would be
unaffected by the treatment and its pharmacokinetic parameters would
remain unchanged between the first and the second examination.
We assessed the repeatability of the parameters describing the
image-derived AIFs, measured in the internal carotids, external carotids
and vertebral arteries, both on the left and right side. At the same time
we assessed the repeatability of the pharmacokinetic parameters in the
muscle using image-derived AIFs obtained from the internal carotids,
external carotids and vertebral arteries, respectively, and compared it
to that obtained using a population averaged AIF.
2. Materials and methods
The study population consisted of 29 patients with advanced stage
squamous cell carcinoma who successfully underwent two MRI ex-
aminations in an ongoing prospective study. This prospective, single-
center study was approved by the Medical Ethics Committee of the
university and has been performed in accordance with the Declaration
of Helsinki. Informed consent was acquired from all patients after full
explanation of the procedures. Previously untreated patients with his-
tologically proven HNSCC, planned for curative (chemo) radiotherapy
were consecutively included from 2013 until 2018. Treatment consisted
of radiotherapy (70 Gy in 35 fractions in a seven week period) with or
without concomitant chemotherapy (cisplatin or cetuximab). Exclusion
criteria were: nasopharyngeal tumors, age < 18 and inadequate image
quality.
Baseline imaging was performed before treatment. Two weeks after
start of treatment a second imaging session was performed with exactly
the same MRI protocol on the same MRI scanner. The basic assumption
in this study is that between both MRI examinations, there was no
systematic effect of treatment on the AIF and on the contrast en-
hancement properties of muscle tissue outside the radiation zone. The
validity of this assumption might seem questionable, because weight
and muscle mass loss is a general effect of the treatment and of the
disease itself [15]. However, bodyweight is a factor that is accounted
for in the administration dose of the contrast agent. Moreover, given the
relatively short amount of time between scans, measurable changes in
healthy muscle tissue were not expected. Thus the comparison between
baseline and during treatment imaging gives the opportunity to assess
repeatability of the AIF and the DCE parameters in muscle.
2.1. Imaging protocol
The DCE MRI acquisition was preceded by a variable flip angle
(VFA) measurement for T1 map estimation and followed by a B1
mapping acquisition. Sequences were acquired on a 3.0 T Ingenuity TF
PET/MR-scanner (Philips Healthcare, Best, the Netherlands) equipped
with a 16-channel neuro-vascular coil. Dotarem® (Guerbet, Roissy,
France) was used as a gadolinium-based contrast agent. The specifica-
tions of the DCE sequence were: 3D T1-FFE (T1-weighted 3D spoiled
gradient echo sequence), TR 3.1 ms, TE 1.48 ms, flip angle 12°, ac-
quired matrix size 184 × 169 × 17, acquired voxel size
1.30 × 1.30 × 4.40 mm3, reconstructed matrix size 320 × 320 × 17,
reconstructed voxel size 0.75 × 0.75 × 4.40 mm3, 75 time frames,
frame duration 4.1 s. A SENSE factor of two was applied in the anterior-
posterior direction. After at least four time frames, the contrast agent
(0.2 ml/kg, concentration 0.5 mmol/ml) was injected at a speed of
3 ml/s using a Medrad® Spectris Solaris® power injector. A flush of
15 ml saline water was injected at 3 ml/s following the contrast bolus.
The VFA measurement was acquired prior to contrast injection with
settings nearly identical to the DCE protocol and five flip angles (2°, 5°,
10°, 15° and 20°). B1 mapping was performed using the method de-
scribed by Yarnykh [16] (3D T1-FFE, TR1 20 ms, TR2 100 ms, TE
3.2 ms, flip angle 50°, acquired matrix size 176 × 177 × 17, acquired
voxel size 1.31 × 1.30 × 4.40 mm3, reconstructed matrix size
320 × 320 × 17, reconstructed voxel size 0.72 × 0.72 × 4.40 mm3).
The B1-map was resliced to the voxel size of the DCE image using linear
interpolation and used for flip angle correction of both the DCE and
VFA image. The VFA image was converted to a T1 map using a linear
least squares fit of Eq. (1) as described by Gupta [17].
The signal intensity equation for a spoiled gradient echo sequence,



















where S is the signal intensity, M0 is the thermal equilibrium magne-
tization and θ is the flip angle. By assuming a fast exchange regime (i.e.
T1−1 = T10−1 + r1C) the contrast concentration dependent signal in-
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where T10 is the pre-contrast longitudinal relaxation time, r1 is the re-
laxivity of the contrast medium and C is the contrast concentration.
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Eq. (4) is identical to Eq. (5) from Heilmann et al. [19] and
equivalent to Eq. (7) from Schabel and Parker [20].
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2.2. Image-derived arterial input functions
The delineated neck arteries were: vertebral arteries, internal car-
otids and external carotids (see Fig. 1). Each artery was manually de-
lineated on the left and right side separately on the third most cranial
slice of the image to minimize the effect of in-flow, while avoiding
inaccuracies at the outer edges of the field of view. Delineation was
performed using in-house developed software by a single observer in
one session. The time frame of maximum enhancement in the arteries
was used during delineation. The later time frames were used to iden-
tify veins, as these show a later time of contrast arrival. If the identified
veins showed overlap with the delineated artery, the delineation was
edited to exclude the vein from the arterial regions of interest. Images
were visually inspected for movement and artefacts. Data was excluded
for further analysis when movement in the arterial regions of interest
was> 2 mm during the DCE image acquisition.
Signal intensities from the arteries were extracted from the dynamic
contrast enhanced images by taking the average over the cross-section
for each arterial region of interest. This was done for left and right
regions of interest separately and for both combined, i.e. considering
left and right regions as one region of interest and taking the average
signal intensity of all voxels within this combined region. Enhancement
of these signals over time was converted to tracer concentration using
Eq. (4), defining S0 as the average of the first four time frames and
assuming a T10 value in blood of 1932 ms taken from literature [21]. A
correction for flip angle θ was performed by using the average value of
the B1-map in each arterial region of interest. A fixed hematocrit level
of 0.42 was used to convert to plasma concentration as described by
Parker et al. [9].
Similarly to Klawer et al. [22], the resulting concentration-time
curves were fitted to the model of Parker et al. [9] to extract parameters
describing the magnitude and shape of the AIFs. An example of this fit is
shown in Fig. 2. Several parameters were defined: maximal con-
centration (peak), time to peak, area under the curve (AUC), full width
half maximum (FWHM), concentration at 180 s (C180) and the ex-
ponential decay constant of the sigmoid modulated exponential in the
Parker model, describing the tail of the concentration-time curve
(washout). To ensure the FWHM only described the width of the first
peak, the FWHM value was considered invalid if the value was> 30 s.
2.3. Kinetic parameters in muscle
A circular region of interest of 6 mm diameter (see Fig. 1) was
placed in the left semispinalis capitis muscle on the DCE image on all
slices except the two most cranial and two most caudal slices, to avoid
inaccuracies at the edges of the field of view. In some patients the
muscle did not lie completely in the field of view and hence less slices
were included in the volume of interest. To minimize spatial mismatch,
delineation of the muscle region on during treatment scans was per-
formed while also showing the pre-treatment delineation. Signals of all
voxels within the volume of interest were extracted from the DCE image
and converted to concentration time curves with correction for the
transmitted radiofrequency field using the B1map and using the T10
values from the T1map. Mean concentration was calculated after con-
verting to concentration for each voxel independently. Mean con-
centration time curves were fitted to the standard Tofts model [1]
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where Ct is the tissue concentration time curve, Cp is the plasma con-
centration time curve and ΔT is the time delay between the plasma
curve and arrival time in tissue. The kinetic parameters Ktrans (rate
constant from plasma to the interstitial space), kep (rate constant from
the interstitial space to plasma) and ve (fractional volume of the in-
terstitial space and the ratio of Ktrans and kep) were estimated. The fit
was performed using a nonlinear least squares fitting procedure, con-
straining the kinetic parameters to positive values and using multiple
starting values [23]. The model was fitted numerically using each
image-derived AIF, and the population averaged AIF as described by
Parker et al. [9]. All data processing was performed in Matlab, version
Fig. 1. Volumes of interest shown on the last dynamic frame of the DCE image.
Arteries were separately delineated on the third most cranial slice, currently
shown. The circular region of interest of 6 mm in diameter was placed manually
in left semispinalis capitis muscle tissue on all slices except the two most cranial
and two most caudal slices.
Fig. 2. Example of fitting the Parker model [9] to the image-derived AIF. The
area under the fit curve is filled with blue, the area under the data is filled with
green. The identified peak value and the value of the fit at 180 s are circled. The
time points used for the FWHM are indicated by squares. (For interpretation of
the references to color in this figure legend, the reader is referred to the web
version of this article.)




Before repeatability assessment, we checked if there were sig-
nificant differences between the repeated measurements by calculating
the average difference and its 95% confidence interval [24]. The re-
peatability of the kinetic parameters was then assessed using the




















where n is the number of patients and xi, 1 and xi, 2 are parameter values
for patient i in session 1 and 2, respectively. A low value of wCV re-
presents a high repeatability. Differences between the AIFs in de-
scriptive parameters of the AIFs and in kinetic parameters of the
muscle, and differences between wCVs were tested for significance
using the nonparametric Wilcoxon matched-pairs signed ranks test.
These tests were performed for left-right comparison of the three ar-
teries, comparison between the arteries (left and right region combined
of internal carotids, external carotids and vertebral arteries were
compared to each other) and each artery (left and right region com-
bined) with the population averaged AIF. The significance level was set
to 0.05, after Bonferroni correction this level was 0.000397. The ana-
lyses were performed with GraphPad Prism, version 7.04.
3. Results
Data from 10 of 29 patients were excluded because movement in the
arterial regions of interest was> 2 mm. Signal from the right vertebral
artery of one patient could not be used because the measured en-
hancement was too high and conversion to concentration was not
possible for the peak signal because enhancement was higher than the
relationship in Eq. (3) permits. The signal of left and right vertebral
artery combined was also excluded for this patient. Plots of image-de-
rived AIFs of the internal carotids, of the tissue time-concentration
curves with model fit and p-values of all tests can be found in the
supplemental materials.
3.1. Image-derived arterial input functions
FWHM values were invalid for the AIF from the left internal and
external carotids in one patient, from the left external carotid in another
patient and from all but the left external carotid in a third patient.
These AIFs showed a relatively low peak and the FWHM therefore did
not describe the width of the peak. Fig. 3 shows boxplots of the para-
meters describing the image-derived AIFs from the pre-treatment da-
tasets. Boxplots from the during-treatment data can be found in the
supplemental material. Left-right differences were small and not sig-
nificant for any of the arteries. The arterial plasma concentrations
measured in this study were generally lower than the population
averaged AIF measured by Parker et al., which gives an approximate
plasma concentration of 10 mM at the peak and 1 mM at 180 s. The
concentrations found in the current study showed median peak con-
centrations below 2 mM and median concentrations at 180 s below
0.5 mM for all image-derived AIFs. The parameters describing the
magnitude of the AIF (i.e. peak, AUC and C180) were lower in the
external carotids, higher in the vertebral arteries and intermediate in
the internal carotids. These differences were significant only between
the external carotids and vertebral arteries. Differences in TTP and
FHWM between the different arteries were not significant. Washout was
significantly different between the internal and the external carotids.
3.2. Repeatability of image-derived arterial input functions
Fig. 4 shows the repeatability of the AIF describing parameters. The
parameters describing the internal carotids generally showed the best
repeatability, except for the peak and TTP. No significant differences
were found between arteries.
3.3. Kinetic parameters in muscle
Five out of the 38 fits to the Tofts Model (Eq. (5))—three from pre-
treatment imaging, two from imaging during treatment, none of which
referring to the same patient—provided unrealistic results when the
population averaged AIF was used: the fitted ve values were above 1
(range 5–160). These data were excluded from the results below. When
an image-derived AIF was used these same data often—though not al-
ways—led to ve values above 1 as well. However, because the ve values
fitted with the image-derived AIFs were in general higher than those
fitted with the image-derived AIF, possibly due to underestimation of
the arterial concentration as result of flow and T2 shortening, the re-
sults were only excluded if the ve was above 3. This criterion led to
exclusion of data of three patients for all image-derived AIFs and of one
patient for all AIFs except those derived from the right vertebral artery
and combined vertebral arteries. These four patients were also excluded
when using the population averaged AIF. One additional patient was
excluded for the AIF derived from the left vertebral artery.
Fig. 5 shows boxplots of the fitted pharmacokinetic parameters in
the muscle before treatment. The boxplots from the during-treatment
data can be found in the supplemental material. No significant differ-
ences between pre- and during-treatment data were observed. No sig-
nificant differences arising from using either a left or right location of
the AIF were observed in any of the parameters for any of the arteries.
The values of all parameters—but most notably Ktrans—were higher
when an image-derived AIF was used, compared to those obtained
using the population averaged AIF. These differences were significant
for all comparisons except kep and Ktrans between the vertebral arteries
and the population averaged AIF. Comparisons between the different
arteries from which the AIFs were derived showed significant differ-
ences between the vertebral arteries and the external carotids for Ktrans
and kep, but not for ve. Values for Ktrans and kep were the largest when
using the external carotids, followed by the internal carotids and the
vertebral arteries. The fitted ve values were sometimes larger than 1
when image-derived AIFs were used, most often when using the ex-
ternal carotids.
3.4. Repeatability of kinetic parameters in muscle
Fig. 6 shows the repeatability of the pharmacokinetic parameters
when using the various image-derived AIFs and the population aver-
aged AIF. The wCV for each of the three parameters was lowest (i.e.
highest repeatability) when a population averaged AIF was used, and
highest when the AIF was derived from the vertebral arteries. However,
no significant difference was observed for any of the comparisons.
4. Discussion
This study shows that image-derived AIFs obtained from different
arteries in the head and neck region in the same patient differ in both
magnitude and shape. Pharmacokinetic parameters in muscle, obtained
using AIFs originated from different arteries, also showed significant
differences. Moreover, use of a population averaged AIF led to sig-
nificantly lower values of Ktrans, kep and ve and slightly better repeat-
ability, although differences in repeatability between different AIF
methods were not significant.
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4.1. Image-derived arterial input functions
The image-derived AIFs from this study seem to underestimate the
arterial plasma concentration when compared to the population aver-
aged AIF or AIFs obtained by DCE-CT [26]. Keil et al. have observed
similar results in the comparison of the internal carotid, superior sa-
gittal sinus, arteries closest to brain lesions and Parker's population
averaged AIF, where arterial regions provided markedly lower con-
centration curves [7]. This is likely caused by blood flow artefacts and
partial volume and T2∗ effects [20,27–29]. These effects are dependent
on the arterial region of interest, which may be why Parker's AIF,
measured in the descending aorta, provides higher concentrations.
Moreover, sensitivity for blood flow and other artefacts is dependent on
the sequence settings [20]. More accurate measurements in the head
and neck region might be achieved with different settings; however,
this generally leads to inferior temporal and spatial resolution [20].
Additional use of phase images has been shown to lead to more re-
peatable AIFs which are less affected by flow [22]. In the current study,
however, phase images were not available.
While there are no significant differences in magnitude between left
Fig. 3. Boxplots with Tukey whiskers of the parameter values describing the image-derived AIFs before treatment. Number of subjects for each boxplot is indicated by
the number below it.
Fig. 4. Bar plots of the wCV of the descriptive parameters of the image-derived AIFs. The error bars indicate the 95% confidence interval.
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and right measured AIFs, the data indicate that the magnitude and
shape of an image-derived AIF are dependent on the choice of the ar-
tery. These differences are larger than what physiological differences
might suggest. They might be partly explained by differences in artery
diameter. Smaller arteries, such as the external carotids, are likely to be
more influenced by partial volume effects, possibly resulting in lower
measured concentration. Moreover, differences in flow velocities can be
responsible for the differences in concentration due to the in-flow ef-
fect, possibly explaining the higher concentration in the vertebral ar-
teries which exhibit lower flow velocity [30].
Also the repeatability of the image-derived AIF seems to be affected
by the choice of artery. The internal carotids seem to give the most
repeatable AIFs, especially in terms of washout. The vertebral arteries
tend to have higher signal enhancement than the other arteries, sug-
gesting that they provide more accurate concentration values.
However, this may also be the reason for the poorer repeatability of the
AIFs from the vertebral arteries: because the relationship between
signal enhancement and concentration in Eq. (3) is nonlinear and
flattens at higher concentrations of contrast agent, the value of the
estimated concentration at low T1 (high concentrations) is more sen-
sitive to noise. This results in increased concentration variability. Use of
a low dose pre-bolus scan can (partially) resolve this saturation effect
and may lead to more repeatable AIFs [31–35]. One other study mea-
sured AIFs in the carotids at multiple time points (to generate a po-
pulation averaged AIF); however, repeatability of the individual mea-
surements was not investigated [36].
4.2. Kinetic parameters in muscle
The differences in the parameters describing the image-derived AIFs
seemed to propagate into the resulting pharmacokinetic parameters.
Use of an image-derived AIF leads to significantly higher parameter
values compared with using a population-based AIF, especially for
Ktrans. This is caused by the lower amplitude of the image-derived AIFs,
as discussed above.
Although the resulting pharmacokinetic values are different, in
terms of repeatability no significant differences between them were
found when using the different AIFs. The repeatability of kep and ve was
comparable when using either a population averaged AIF or an AIF
derived from the internal carotids. This result differs from the study of
Rijpkema et al. [11], who found that repeatability of kep was better if
individual AIFs were used. In their dataset, 6 patients are included with
a tumor in the head and neck region; however, a different sequence is
used (the flip angle is particularly different) and this may explain the
disparity with our study. Peled et al. [5] also found that kep repeat-
ability improved by using individual AIFs, although their study covers
the prostate. In accordance with some literature [9,10], but contra-
dicting other [12], the repeatability of Ktrans seems to improve when a
population averaged AIF is used. Ideally, use of an image-derived AIF
corrects for variability in cardiac output within the patients over time,
thus leading to a better repeatability of the pharmacokinetic para-
meters. Apparently, however, the variability introduced by the AIF
measurement counteracts this effect. Variability could be caused by
partial volume effects, B1 errors and flow enhancement artefacts. Be-
cause this is different for other acquisition settings, the generalizability
of our results is limited.
When the population averaged AIF was used, the tissue curves in
five subjects were fitted with ve above 1, indicating that the data do not
adhere to the theoretical model, either because the population averaged
AIF cannot lead to the tissue time-concentration curve, or the tissue
time-concentration curve is incorrect. The latter might be explained by
inaccurate T1 estimation or errors in B1 that are not accounted for by
the B1 correction. This would explain why the model also produced
outliers when the image-derived AIFs were used in four of the five
cases. In one case the image-derived AIFs showed a dispersed shape and
fitting led to reasonable pharmacokinetic parameter values and a better
Fig. 5. Boxplots with Tukey whiskers of the pharmacokinetic parameter values in the muscle before treatment. Number of subjects for each boxplot is indicated by
the number below it.
Fig. 6. Bar plots of the wCV of the muscle pharmacokinetic parameters. The error bars indicate the 95% confidence interval.
T. Koopman, et al. Magnetic Resonance Imaging 68 (2020) 1–8
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fit, indicating that use of a population averaged AIF was inappropriate
in this case.
4.3. Limitations
More than one third of the data could not be evaluated. Deriving the
AIF from the image is problematic when the patient moves or swallows
during acquisition. Motion correction for these, often small and quick,
movements is not straightforward and was not performed in this study.
Use of a population averaged AIF largely overcomes this problem, al-
though movement can also affect signals from the tissue.
Repeatability estimates within tumor and lymph nodes are neces-
sary for biomarker validation of DCE-MRI pharmacokinetic parameters
in the head and neck cancer, such as HNSCC. However, due to the setup
of this study such estimates could not be investigated, because between
baseline and follow-up the patients underwent chemo radiotherapy.
Moreover, the repeatability estimates reported for muscle cannot be
extrapolated to, for example, tumor tissue; the different tissue char-
acteristics in tumor (or tissues in which they arise) lead to different
pharmacokinetic parameter values and their repeatability is likely dif-
ferent [37]. The semispinalis capitis muscle was chosen as it is located
outside the radiated area. However, the combination of (chemo)
radiotherapy and the ongoing disease might have some systemic effects,
even within this short period of time between scans. As reported, no
significant differences were found between pre- and during-treatment
kinetic parameters in muscle; however, if the effects of disease and
therapy caused an increased variability, the wCV's reported here may
be overestimated. Nonetheless, we believe that the repeatability of the
pharmacokinetic parameters in the muscle region can still be a useful
tool for comparison of the use of different AIFs as input of the model.
5. Conclusion
Significant variations were found in the AIFs obtained from dif-
ferent arteries in the head and neck region. Image-derived AIFs mea-
sured in the internal carotids show a trend to better repeatability for
both the AIF itself and for the pharmacokinetic parameters estimated in
muscle tissue. However, the image-derived AIF does not improve re-
peatability of the pharmacokinetic parameters compared to a popula-
tion averaged AIF. Moreover, patient movement during acquisition,
which can be common in the head and neck region, is likely to disturb
AIF measurement. For these reasons, the use of a population averaged
AIF in this patient population seems to be preferable for pharmacoki-
netic analysis of DCE-MRI when absolute PK parameter values are not
of major concern.
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